Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Hemophilia or Blood Coagulation Disorders Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Hemophilia or Blood Coagulation Disorders Projects
--Artisan Pharma, Inc.
--ARYx Therapeutics, Inc.
--Asahi Kasei Corporation
--Bayer Ag
--Green Cross Corporation
--GTC Biotherapeutics Inc
--Ipsen Ltd
--LEO Pharma A/S
--Novo-Nordisk A/S
--Octagen Corporation

--Top Companies in early stage Hemophilia or Blood Coagulation Disorders Projects
--Avigen Inc /DE
--Asklepios BioPharmaceutical Inc.
--Bio3 Research
--Baxter International Inc
--Biovitrum AB
--Biogen Idec Inc
--Eli Lilly & Co
--CSL Behring
--erly ZLB Behring)
--Green Cross Corporation
--Genentech Inc
--Inspiration Biopharmaceuticals
--GTC Biotherapeutics Inc
--Living Cell Technologies Ltd
--KAKETSUKEN
--Oxford BioMedica plc
--Novo-Nordisk A/S
--Shire plc
--Selexys Pharmaceuticals Corporation
--Tolerx, Inc.
--Thrombotargets Corporation

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View